Researchers identify gene responsible for mesenchymal stem cells' stem-ness'

January 22, 2018, The Scripps Research Institute
Credit: CC0 Public Domain

Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering these therapies to patients worldwide.

Mesenchymal stem cells (MSCs) are popular tools for these therapies because they can differentiate into a variety of mature cell types such as bone, fat and cartilage. They also support hematopoiesis—the formation of blood cells—and secrete beneficial factors that promote tissue repair. Unfortunately, scientists often struggle to predict how these cells will act in different environments in the body.

Researchers on the Florida campus of The Scripps Research Institute (TSRI) recently published a study in the journal Cell Death and Differentiation identifying factors crucial to MSC differentiation, providing insight into how these cells should be studied for clinical purposes.

Primary MSCs from bone marrow are delicate, and it´s difficult to keep them alive in a petri dish. For this reason, most scientists studying them use cell lines, cells that have been altered to live and replicate indefinitely. To create immortal MSC lines, scientists delete a gene called p53 required for the cells to undergo normal, programmed cell death, called apoptosis. The new study, conducted by researchers in the lab of TSRI Professor Donald Phinney, PhD, shows that the gene influences far more than just apoptosis; it is also a master regulator of the cells' ability to differentiate.

"Many publications have used immortalized cells as MSC surrogates, but they may not mean much if they don't have functionally accurate p53," says Siddaraju Boregowda, PhD, a TSRI research associate and one of the study's two lead authors.

The researchers compared cells cultured from mice that did not express the with cells that came from normal mice. They found that the level of active p53 was the master regulatory factor in determining how MSCs grow and differentiate. The study explains that the gene exerts its effects through its interactions with as well as two transcription factors: TWIST2 and PPARG.

When the researchers deleted p53 completely, the cells became immortal but quickly developed into bone. They lost their ability to promote hematopoiesis or become other types of cells, like fat. A low level of p53 induced TWIST2, which kept the MSCs in a stem state, rather than promoting any differentiation. A slightly higher level of p53 induced PPARG and reactive oxygen species, which led the cells to differentiate into , but not bone. At even higher levels of p53, the cells died.

A basal level of p53 in cells in the culture is required for them to act as an accurate model for cells in the body, explains Veena Krishnappa, PhD, the study's other lead author, previously a postdoctoral researcher in Phinney's lab.

In addition to suggesting that the dramatic effects of deleting p53 may make MSC cell lines an inappropriate surrogate to predict the cells' behavior in clinical applications, the study also suggests that inactivation of p53 may play multiple roles in the progression of bone cancers.

"P53 inactivation not only promotes sustained growth but also makes the insensitive to oxidative stress and short-circuits pathways that constrain cellular differentiation. Each of these changes likely contribute significantly to tumorigenesis and tumor progression," says Phinney. "Continuing to delineate the important role of MSCs in skeletal disease may open the door to devising new therapeutic interventions."

Explore further: Scientists find way to predict activity of stem cells

More information: Siddaraju V. Boregowda et al. Basal p53 expression is indispensable for mesenchymal stem cell integrity, Cell Death & Differentiation (2018). DOI: 10.1038/s41418-017-0004-4

Related Stories

Scientists find way to predict activity of stem cells

February 29, 2016
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time developed a way to predict how a specific type of stem cell will act against different diseases. With more than 500 stem ...

New study reveals how specialized cells help each other survive during times of stress

November 3, 2015
Nov. 3, 2015 - A team led by scientists from the Florida campus of The Scripps Research Institute (TSRI) and the University of Pittsburgh has shown for the first time how one set of specialized cells survives under stress ...

Recommended for you

How a single faulty gene can lead to lupus

December 18, 2018
A research team at the Academy of Immunology and Microbiology, within the Institute for Basic Science (IBS) & Pohang University of Science and Technology (POSTECH) in South Korea has discovered the role of a key gene involved ...

New genetic testing technology enhances precision of analysis of clinical biomarkers

December 18, 2018
Estonian scientists have announced the invention of a genetic testing technology to analyse the number of clinical biomarkers at the single-molecule level, which enhances the sensitivity of tests in precision medicine and ...

Get a warrant: Researchers demand better DNA protections

December 18, 2018
New laws are required to control access to medical genetic data by law enforcement agencies, an analysis by University of Queensland researchers has found.

Geneticists make new discovery about how a baby's sex is determined

December 14, 2018
Medical researchers at Melbourne's Murdoch Children's Research Institute have made a new discovery about how a baby's sex is determined—it's not just about the X-Y chromosomes, but involves a 'regulator' that increases ...

Scientists identify method to study resilience to pain

December 14, 2018
Scientists at the Yale School of Medicine and Veterans Affairs Connecticut Healthcare System have successfully demonstrated that it is possible to pinpoint genes that contribute to inter-individual differences in pain.

Researchers uncover molecular mechanisms linked to autism and schizophrenia

December 13, 2018
Since the completion of the groundbreaking Human Genome Project in 2003, researchers have discovered changes to hundreds of places in the DNA, called genetic variants, associated with psychiatric diseases such as autism spectrum ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.